Fig. 7
From: Genome-wide profiling of alternative splicing in glioblastoma and their clinical value

GSEA analysis of the risk prediction model. (A) GSEA analysis based on KEGG pathway database. (B) GSEA analysis based on Reactome pathway database
From: Genome-wide profiling of alternative splicing in glioblastoma and their clinical value

GSEA analysis of the risk prediction model. (A) GSEA analysis based on KEGG pathway database. (B) GSEA analysis based on Reactome pathway database